Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size By Type (Analgesics, NSAIDs), By Application (Hospital Pharmacy, Online Drug Stores), By Geographic Scope And Forecast
Report ID: 251793|No. of Pages: 202
Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size By Type (Analgesics, NSAIDs), By Application (Hospital Pharmacy, Online Drug Stores), By Geographic Scope And Forecast
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size And Forecast
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e., 2024 to 2031.
The high growth of the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market is due to an increase in the number of cancer cases, as well as an increase in patient and healthcare provider awareness of the hand-foot syndrome. Other factors driving the growth of this market include the availability of new treatments and increased government support for R&D activities. The Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Definition
Acral erythema, also known as palmar-plantar erythrodysesthesia or hand-foot syndrome, is characterized by swelling, redness, paraesthesia (numbness), and desquamation (skin peeling) of the palms, soles, and, in rare cases, the knees and elbows. Acryl erythema is a common adverse drug reaction that occurs after several months of treatment with chemotherapeutic agents, gemcitabine, and fluorouracil being the most common culprits. Chemotherapy-induced acryl erythema is a dose-dependent condition that can be reversed by discontinuing chemotherapy or reducing the dose.
To relieve pain and edema caused by chemotherapy, analgesics and antihistaminic drugs are used to treat acryl erythema. The increased use of chemotherapeutic agents as cancer incidence rises is the primary growth driver in the global chemotherapy-induced acral erythema treatment market. Furthermore, lifestyle changes and an increase in the number of smokers are some secondary factors responsible for the rise in the Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=251793
Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Overview
Data from two large phases III studies were used to develop a longitudinal model to predict hand-and-foot syndrome (HFS) dynamics in capecitabine patients. The capecitabine arms included a large number of patients; some were chosen at random to build the model, while others were assigned to model validation. The proportional odds model, a sigmoidal maximum effect model driven by capecitabine accumulation as estimated by a kinetic-pharmacodynamic model, and a Markov process were used to generate a risk score for developing HFS. The higher the risk of HFS, the lower the calculated creatinine clearance value at inclusion. Visual and statistical predictive checks were used to validate the model.
Furthermore, the treatment of hand-foot syndrome is primarily symptomatic. If there is swelling or inflammation, topical steroid creams may be prescribed, or cancer treatment may be delayed until the symptoms improve. To manage this side effect, the chemotherapy dose is sometimes adjusted. In addition, moisturizers are advised for dry skin. Medicated creams, such as urea cream, can sometimes help get rid of rough skin. Celebrex is sometimes used to treat pain, but it is not commonly prescribed. They should refrain from picking at dry skin, breaking blisters, or immersing their hands in hot water. When moisturizing, avoid vigorously rubbing the creams in, and is expected the growth of the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market even further.
Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Segmentation Analysis
The Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market is segmented on the basis of Type, Application, And Geography.
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, By Type
• Analgesics
• Anti-Inflationary & Anti-Edematous Agents
• NSAIDs
• Others
Based on Type, The market is segmented into Analgesics, Anti-Inflationary & Anti-Edematous Agents, NSAIDs, and Others. Anti-Inflationary & Anti-Edematous Agents medications work to reduce swelling and inflammation. They are most commonly used to treat arthritis, bursitis, and tendinitis. These medications could be taken orally or topically. Ibuprofen, naproxen, and celecoxib are common anti-inflammatory and anti-edematous agents and increasing the market growth of the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market globally.
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, By Application
• Pharmacy & Drugstores
• Hospital Pharmacy
• Online Drug Stores
• Others
Based on Application, The market is segmented into Pharmacy & Drugstores, Hospital Pharmacy, Online Drug Stores, and Others. Treatment for Chemotherapy-Induced Acral Erythema (Hand-Foot Syndrome) is available in pharmacies and drugstores for the treatment of chemotherapy-induced acral erythema, also known as hand-foot syndrome. This is a condition that causes hand and foot redness, swelling, and pain. Symptoms typically appear during or after chemotherapy treatments. Chemotherapy-Induced Acral Erythema (Hand-Foot Syndrome) Treatment can help alleviate the symptoms of this condition, which is driving the market growth increasing the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market globally.
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, By Geography
• North America
• Europe
• Asia Pacific
• Rest of the world
On the basis of Geography, The Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market is segmented into North America, Europe, Asia Pacific, and the Rest of the world. Because of the high prevalence of cancer and raising awareness about early detection and treatment of cancer, North America is expected to dominate the Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, thereby it will be driving the growth of the region’s Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market in the coming years.
Key Players
The “Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Taro, Oceanside Pharmaceuticals, Pfizer, Novartis, A-S Medication Solutions, Preferred Pharmaceuticals, Syntex Pharmaceuticals, Valeant Canada, Technilab Pharma, Allergan.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
• In Feb 2022, Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) recently announced that it had completed its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s global operations and assets.
• In May 2022, Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. recently announced that they have reached a definitive agreement in which Pfizer will acquire Biohaven, the maker of an innovative dual-acting migraine therapy approved for both acute treatment and episodic migraine prevention in adults.
• In Dec 2021, Novartis will acquire Gyroscope Therapeutics, which will add a one-time gene therapy that has the potential to transform care for geographic atrophy, a leading cause of blindness.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2021-2023 |
| Key Companies Profiled | Taro, Oceanside Pharmaceuticals, Pfizer, Novartis, A-S Medication Solutions, Preferred Pharmaceuticals, Syntex Pharmaceuticals. |
| Segments Covered | • By Type |
| Customization scope | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (HAND-FOOT SYNDROME) TREATMENT MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (HAND-FOOT SYNDROME) TREATMENT MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (HAND-FOOT SYNDROME) TREATMENT MARKET, BY TYPE
5.1 Overview
5.2 Analgesics
5.3 Anti-Inflammatory & Anti-Edematous Agents
5.4 NSAIDs
5.5 Others
6 GLOBAL CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (HAND-FOOT SYNDROME) TREATMENT MARKET, BY APPLICATION
6.1 Overview
6.2 Pharmacy & Drugstores
6.3 Hospital Pharmacy
6.4 Online Drug Stores
6.5 Others
7 GLOBAL CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (HAND-FOOT SYNDROME) TREATMENT MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Rest of the World
7.5.1 Latin America
7.5.2 Middle East and Africa
8 GLOBAL CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (HAND-FOOT SYNDROME) TREATMENT MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
9 COMPANY PROFILES
9.1 Taro
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Oceanside Pharmaceuticals
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Pfizer
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Novartis
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 A-S Medication Solutions
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Preferred Pharmaceuticals
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Syntex Pharmaceuticals
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Valeant Canada
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Technilab Pharma
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Allergan
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 KEY DEVELOPMENTS
10.1 Product Launches/Developments
10.2 Mergers and Acquisitions
10.3 Business Expansions
10.4 Partnerships and Collaborations
11 Appendix
11.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market
Download Sample Report